At the news
? NEUTRALIMPACT 1/10 3 filed Jun 10, 2026 at 18:20 ET
Timothy Coughlin filed a Form 3 initial statement of beneficial ownership with the SEC, reporting zero shares of Vir Biotechnology common stock. This is a routine filing for a new Section 16 reporting person who has no current holdings, and carries no material trading or financial signal.
- Form 3 filed by Timothy Coughlin as a new Section 16 reporting person on June 10, 2026
- Filing reports 0 shares of common stock beneficially owned as of June 9, 2026
- A power of attorney was also filed, authorizing certain individuals to execute Section 16 filings on Coughlin's behalf
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access